
Fortrea Holdings (NASDAQ:FTRE) a global leader in contract research organizations (CROs), assists pharmaceutical, biotechnology, and medical device companies in bringing new treatments and technologies to market. They don't directly offer products or services to consumers, but instead, provide comprehensive solutions throughout the drug and device development process. This includes managing clinical trials, ensuring regulatory compliance, and analyzing data. By supporting the research and development of innovative healthcare solutions, Fortrea plays a crucial role in advancing healthcare and improving patient outcomes.